Delivery Order SPE2DB22D2009-SPE2DB25FM0EX
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,610.76 for 500 tablets of Mucus Relief ER 600 mg, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with DLA....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mucus Relief ER 600 mg tablets (500-count units) with a ceiling value of $1,572.44 and an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Mucus Relief DM ER 600-30 mg tablets (40-count package) with a ceiling value of $2,917.37. This is a firm fixed-price delivery order with a completion date of October 20, 2025, issued with no set-aside designation under competitive procurement procedures. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.38 on August 13, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mucus Relief ER 600 mg tablets in unit dose packaging (100 count) with a contract value of $2,846.14. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $3,863.83. The award represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procedures,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,706.85 on July 28, 2025, for the supply of Mucinex DM ER 600-30 mg tablets in quantities of 20 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,746.61, is for the delivery of "MUCUS RELIEF ER 600 MG TABLET 500S" and has a completion date of March 6, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- The Defense Logistics Agency awarded a $2,655.18 delivery order to AmerisourceBergen Drug Corp for Mucinex DM ER 600-30 mg tablets (20-count) on July 17, 2025, with an ultimate completion date of July 18, 2025. This non-set-aside contract utilizes a firm fixed price structure and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,106.16 to AmerisourceBergen Drug Corp for 500 tablets of Mucus Relief ER 600 mg, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB25FM0EXDelivery Order
AmerisourceBergen Drug Corp was awarded a Delivery Order valued at $3,061.45 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Mucus Relief DM ER 600-30 mg tablets (40-count). This is a firm fixed price, non-set-aside contract with a completion date of July 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that authorizes the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's federal contract portfolio demonstrates its capability to competitively deliver diverse medical commodities across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. Through its DLA prime contract, AmerisourceBergen supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning it as a key component of the military medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/14/25 |